Cottle R. “Liver repopulation by acetaminophen selection of hepatocytes edited ex vivo using nonviral delivery approaches,” Invited speaker, American Society of Gene and Cell Therapy 26TH Annual Meeting, Los Angeles, California (May 19, 2023).

Cottle R. “A unique journey in academia to advance cell-based gene editing approaches for genetic diseases affecting the liver,” Invited speaker, The 3rd Annual Life Science Women’s Conference, University of South Florida (September 21, 2022).

Cottle R. “Correcting Inherited Metabolic Liver Disease by ex vivo genome editing using nonviral delivery approaches,” Invited speaker, South Carolina Bioengineering Center of Regeneration and Formation of Tissues, Third Annual Meeting Phase III, Clemson University (March 11, 2022).

Cottle R. “Correcting Inherited Metabolic Liver Disease by ex vivo genome editing using nonviral delivery approaches,” Invited speaker, Picture A Scholar at Clemson, Inaugural Women’s Scholar Symposium (March 10, 2022).

Cottle R. “Correcting Inherited Metabolic Liver Disease by ex vivo genome editing using nonviral delivery approaches,” Invited seminar, Biomedical Engineering Seminar, Tufts University, virtual seminar (January 31, 2022)

Cottle R. “Correcting inherited metabolic liver diseases by ex vivo genome editing using nonviral delivery approaches,” Invited seminar, Center for Human Genetics, Clemson University, virtual seminar (September 13, 2021)

Cottle R. “Ex vivo genome editing as a therapeutic approach for genetic diseases”, Invited seminar, Bioengineering Research Seminar, University of Maryland, College Park, MD (February 5, 2021).

Cottle R. “Ex vivo genome editing as a therapeutic approach for genetic diseases”, Invited seminar, Bioengineering Research Seminar, Rochester Institute of Technology, Rochester, NY (March 3, 2020).

Cottle R. “Ex vivo genome editing as a therapeutic approach for inherited metabolic diseases affecting the liver”, Invited seminar, Research Seminar, Division of Digestive Diseases, Emory University School of Medicine, Atlanta, GA (January 30, 2020)

Cottle R. “Ex vivo genome editing as a therapeutic approach for genetic diseases”, Invited seminar, Research Seminar, Southern Wesleyan University, Central, SC (January 24, 2020).

Cottle R. “Ex vivo genome editing as a therapeutic approach: Engineering the delivery system and critical challenges”, Invited seminar, Regenerative Medicine & Cell Biology, Digestive Disease Research Center Seminar Series, Medical University of South Carolina, Charleston, SC (April 10, 2019).

Cottle R. “Ex vivo genome editing as a therapeutic approach: Engineering the delivery system and critical challenges”, Invited seminar, Seminar Series, Genetics and Biochemistry, Clemson University, Clemson, SC (March 1, 2019).

Cottle R. “The promise of cell-based gene therapies using non-viral delivery approaches”, Invited seminar, Center for Molecular and Translational Medicine, Seminar Series, Georgia State University, Atlanta, GA (November 21, 2018).

Cottle R, “The promise of cell-based gene therapies using non-viral delivery approaches”, Invited conference speech, 2nd Annual Summit on Stem Cell Research, Cell & Gene Therapy, Atlanta, GA (November 9, 2018).

Cottle R, “Towards ex vivo gene editing in hepatocytes for treatment of inherited liver disease”, Invited conference speech, Genetics Symposium, Clemson, SC (September 27, 2018).

Cottle R, “Novel gene therapy strategy using CRISPR-Cas nucleases and donor template for metabolic liver disease”, Invited conference speech, SC INBRE Science Symposium, Columbia, SC (August 10, 2018).

Cottle R, “The promise of cell-based gene therapies using non-viral delivery approaches”, Invited conference speech, International Biomaterials Symposium, Madren Conference Center, Clemson, SC (April 16, 2018).

Cottle R, “Glass microcapillary mediated microinjection of β-globin targeting TALENs into K562 cells”, Graduate and Postdoc Seminar Series, Georgia Institute of Technology, Atlanta, GA (November 13, 2014).

Cottle R, “Microinjection and nucleofection methods of delivering β-globin targeting TALENs into K562 cells”, Nanomedicine Development Center for Nucleoprotein Machines Internal Review Meeting, Atlanta, GA (October 7, 2014).

Cottle R, “Quantifying the effects of nuclease delivery and gene correction on the functionality of hematopoietic stem cells”, Molecular Biophysics Seminar Series, Georgia Institute of Technology, Atlanta, GA (February 6, 2012).